Halitozis: Güncel Sınıflama, Tanı ve Tedavi Yaklaşımları

Halitozis, bireylerin ekspirasyon havasında mevcut olan ağız içi veya ağız dışı faktörler ile ilişkili nahoş kokuyu ifade etmektedir. Günümüzde bireylerin ideal hayat tarzları ve kişisel görünümlerine verdikleri önemin giderek artması nedeniyle, ağız kokusu önemli bir stres ve rahatsızlık kaynağı haline gelmiştir. Sosyal ve psikolojik olumsuz etkilerin yanı sıra, halitozis vücuttaki ciddi bir sistemik hastalığın habercisi de olabilmektedir. Halitozis ile ilişkili mevcut sınıflandırmaların standardize olmaması ve farklı ağız kokusu tiplerini net şekilde tanımlamaması nedeniyle yakın geçmişte yeni bir sınıflandırma sistemi önerilmiştir. Bu makalenin amacı, toplumun büyük bölümünü etkileyen ciddi bir sağlık sorunu olan halitozis için önerilen güncel sınıflandırma sistemi ile birlikte, teşhis yöntemleri ve tedavi yaklaşımlarını sunmaktır.

Halitosis: New Classification, Diagnosis and Management

Halitosis describes unfavourable/unacceptable odour in the expired air originating from both intra-oral and extra-oral causes. Individuals with bad breath suffer social anxiety which eventually leads to poor oral health-related quality of life. Besides its adverse impacts on psychology and social aspects, halitosis can also be an indicator of severe systemic diseases. A new standardized and etiology-based classification system has been proposed recently to overcome drawbacks of former classification systems such as non-standardized typing and lack of specific description for different types of halitosis. The aim of this article is to present current classification system and etiological factors for halitosis, along with diagnostic methods and therapeutic approaches.

PDF

___

1. Scully C, Greenman J. Halitology (breath odour: aetiopathogenesis and management): Breath odour diagnosis and management. Oral Dis 2012;18:333– 45.
2. Bodrumlu, E, Köprülü, H, Sümer, A. Halitozis: Teşhis, Sınıflama ve Tedavi. Ondokıız Mayis Univ Dis Hekim Fak Derg 2005;6:115-121
3. Renvert S, Noack MJ, Lequart C, Roldán S, Laine ML. The Underestimated Problem of Intra-Oral Halitosis in Dental Practice: An Expert Consensus Review. Clin Cosmet Investig Dent 2020;12:251-262.
4. Yaegaki K, Coil J M. Examination, classification, and treatment of halitosis; clinical perspectives. J Can Dent Assoc 2000; 66: 257–261.
5. Loesche WJ, Kazor C. Microbiology and treatment of halitosis. Periodontol 2000 2002;28:256–79.
6. Silva MF, Leite FRM, Ferreira LB, et al. Estimated prevalence of halitosis: a systematic review and metaregression analysis. Clin Oral Investig 2018;22:47- 55.
7. Soares LG, Tinoco EMB. Prevalence and related parameters of halitosis in general population and periodontal patients. OA Dentistry 2014; 25;2:4.
8. Yıldızer Kerı̇ş E, Güngör K, Özütürk Ö, Özdede M. Prevalence of halitosis and evaluation of etiological factors in a Turkish subpopulation. Atatürk Üniv Diş Hekim Fak derg 2016;26:0–0.
9. Aydin M, Harvey-Woodworth CN. Halitosis: a new definition and classification. Br Dent J 2014;217: E1.
10. Zürcher A, Filippi A. Findings, diagnoses and results of a halitosis clinic over a seven year period. Schweiz Monatsschr Zahnmed 2012;122:205-16.
11. Quirynen M, Dadamio J, Van den Velde S, et al. Characteristics of 2000 patients who visited a halitosis clinic. J Clin Periodontol 2009;36:970–975. x
12. Hughes FJ, McNab R. Oral malodour--a review. Arch Oral Biol 2008;53 Suppl 1: p 1-7.
13. Aydin M, Mısırlıgil A (eds). Halitosis: Oral microbiology. MN Medical & Nobel, Ankara, 2012, 97–104.
14. Hampelska K, Jaworska MM, Babalska ZŁ, Karpiński TM. The Role of Oral Microbiota in IntraOral Halitosis. J Clin Med 2020; 2;9:2484.
15.Barrak I, Stájer A, Gajdács M, Urbán E. Small, but smelly: the importance of Solobacterium moorei in halitosis and other human infections. Heliyon. 2020; 29;6: e05371.
16. Kapoor U, Sharma G, Juneja M, Nagpal A. Halitosis: Current concepts on etiology, diagnosis and management. Eur J Dent. 2016;10:292–300.
17. Tsuneishi M, Yamamoto T, Kokeguchi S, Tamaki N, Fukui K, Watanabe T. Composition of the bacterial flora in tonsilloliths. Microbes Infect 2006; 8:2384-9.
18. Hirano I, Kahrilas PJ, Pandolfino JE, et al. (editors) Textbook of gastroenterology 5th edition 2009 Blackwell Pub. Chichester, West Sussex pp. 732,742,772,951.
19 Yoo SH, Jung HS, Sohn WS, et al. Volatile sulfur compounds as a predictor for esophagogastroduodenal mucosal injury. Gut Liver 2008; 2:113-8.
20. Kislig K, Wilder-Smith CH, Bornstein MM, Lussi A, Seemann R. Halitosis and tongue coating in patients with erosive gastroesophageal reflux disease versus nonerosive gastroesophageal reflux disease. Clin Oral Investig 2013;17:159-65.
21. Tangerman A, Winkel EG. Extra-oral halitosis: an overview. J Breath Res 2010;4:017003.
22. Whittle CL, Fakharzadeh S, Eades J, Preti G. Human breath odors and their use in diagnosis. Ann N Y Acad Sci 2007; 1098:252-66
23. Amann A, Costello Bde L, Miekisch W, et al. The human volatilome: volatile organic compounds (VOCs) in exhaled breath, skin emanations, urine, feces and saliva. J Breath Res 2014;8:034001.
24. Dryahina K, Španěl P, Pospíšilová V, et al. Quantification of pentane in exhaled breath, a potential biomarker of bowel disease, using selected ion flow tube mass spectrometry. Rapid Commun Mass Spectrom 2013; 15;27:1983-92.
25. Dadamio J, Van den Velde S, Laleman W, et al. Breath biomarkers of liver cirrhosis. J Chromatogr B Analyt Technol Biomed Life Sci 2012; 15; 905:17-22.
26. Nakhleh MK, Quatredeniers M, Haick H. Detection of halitosis in breath: Between the past, present, and future. Oral Dis 2018;24:685-695.
27. Díaz de León-Martínez L, Rodríguez-Aguilar M, Gorocica-Rosete P, et al. Identification of profiles of volatile organic compounds in exhaled breath by means of an electronic nose as a proposal for a screening method for breast cancer: a case-control study. J Breath Res 2020;14:046009.
28. Dragonieri S, Scioscia G, Quaranta VN, et al. Exhaled volatile organic compounds analysis by enose can detect idiopathic pulmonary fibrosis. J Breath Res 2020; 21;14:047101.
29. Phillips KA, Menard W. Olfactory reference syndrome: demographic and clinical features of imagined body odor. Gen Hosp Psychiatry 2011 ;33:398-406.
30. Torsten M, Gómez-Moreno G, Aguilar-Salvatierra A. Drug-related oral malodour (halitosis): a literature review. Eur Rev Med Pharmacol Sci 2017;21:4930- 4934.
31. Van den Broek AM, Feenstra L, de Baat C. A review of the current Literature on aetiology and measurement methods of halitosis. J Dent 2007; 35:
32. Laleman I, Dadamio J, De Geest S, Dekeyser C, Quirynen M. Instrumental assessment of halitosis for the general dental practitioner. J Breath Res 2014;8:017103.
33. Salako NO, Philip L. Comparison of the use of the Halimeter and the Oral Chroma2 in the assessment of the ability of common cultivable oral anaerobic bacteria to produce malodorous volatile sulfur compounds from cysteine and methionine. Med Princ Pract 2011; 20: 75-9.
34. Shimura M, Yasuno Y, Iwakura M, et al. A new monitor with a zinc-oxide thin film semiconductor sensor for the measurement of volatile sulfur compounds in mouth air. J Periodontol 1996;67:396– 402.
35. Hanada M, Koda H, Onaga K et al. Portable oral malodor analyzer using highly sensitive InO gas sensor combined with a simple gas chromatography system [Internet]. Oralchroma.es. 2003 [cited 2021 Feb 27]. Available from: http://www.oralchroma.es/ informacion-cientifica/Hanada-2003.pdf
36. Laleman I, Dekeyser C, Wylleman A, Teughels W, Quirynen M. The OralChromaTM CHM-2: a comparison with the OralChromaTM CHM-1. Clin Oral Investig 2020;24:2829–36.
37. Morita M, Musinski DL, Wang HL. Assessment of newly developed tongue sulfide probe for detecting oral malodor. J Clin Periodontol 2001; 28: 494–496.
38. Gasparri R, Sedda G, Spaggiari L. The Electronic Nose's Emerging Role in Respiratory Medicine. Sensors (Basel) 2018; 10;18:3029.
39. Wilson AD. Application of electronic-nose technologies and VOC-biomarkers for the noninvasive early diagnosis of gastrointestinal diseases. Sensors (Basel) 2018;18:2613.
40. van de Goor RM, Leunis N, van Hooren MR, Francisca E, Masclee A, Kremer B, Kross KW. Feasibility of electronic nose technology for discriminating between head and neck, bladder, and colon carcinomas. Eur Arch Otorhinolaryngol 2017;274:1053-1060.
41. Andrade JA, Feres M, Figueiredo LC, Salvador SL, Cortelli SC. The ability of the BANA Test to detect different levels of P. gingivalis, T. denticola and T.forsythia. Braz Oral Res 2010;24:224-30.
42. Yoneda M, Masuo Y, Suzuki N, Iwamoto T, Hirofuji T. Relationship between the β-galactosidase activity in saliva and parameters associated with oral malodor. J Breath Res 2010;4:017108.
43. Aylıkcı BU, Colak H. Halitosis: From diagnosis to management. J Nat Sci Biol Med 2013;4:14-23.
44. Amano A, Yoshida Y, Oho T, Koga T. Monitoring ammonia to assess halitosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002;94:692-6.
45. Garibyan L, Avashia N. Polymerase chain reaction. J Invest Dermatol 201;133:1-4.
46. Tanaka M, Yamamoto Y, Kuboniwa M, et al. Contribution of periodontal pathogens on tongue dorsa analyzed with real-time PCR to oral malodor. Microbes Infect 2004;6:1078–83.
47. Oshiro A, Zaitsu T, Ueno M, Kawaguchi Y. Characterization of oral bacteria in the tongue coating of patients with halitosis using 16S rRNA analysis. Acta Odontol Scand 2020;78:541–6.
48.Bodrumlu E, Sumer P, Bulucu B, Koprulu H. Effectiveness of different tongue cleaning instruments in assessment of oral malodour. Int J Clin Dent 2011;4: 321-327.
49. Van der Sleen MI, Slot DE, Van Trijffel E, Winkel EG, Van der Weijden GA. Effectiveness of mechanical tongue cleaning on breath odour and tongue coating: A systematic review. Int J Dent Hyg 2010; 8:258–68.
50. Porter SR, Scully C. Oral malodour (halitosis). BMJ 2006;333:632–5.
51.Benic GZ, Farella M, Morgan XC, Viswam J, Heng NC, Cannon RD, et al. Oral probiotics reduce halitosis in patients wearing orthodontic braces: a randomized, triple-blind, placebo-controlled trial. J Breath Res 2019;13:036010.
52. Suzuki N, Yoneda M, Tanabe K, Fujimoto A, Iha K, Seno K, et al. Lactobacillus salivarius WB21-- containing tablets for the treatment of oral malodor: a double-blind, randomized, placebo-controlled crossover trial. Oral Surg Oral Med Oral Pathol Oral Radiol 2014;117:462–70